Repurposing lipid-lowering drugs on asthma and lung function: evidence from a genetic association an...
Repurposing lipid-lowering drugs on asthma and lung function: evidence from a genetic association analysis
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
To explore the correlation between asthma risk and genetic variants affecting the expression or function of lipid-lowering drug targets.
We conducted Mendelian randomization (MR) analyses using variants in several genes associated with lipid-lowering medication targets: HMGCR (statin target), PCSK9 (alirocumab target), NPC1L1 (ezetimibe target),...
Alternative Titles
Full title
Repurposing lipid-lowering drugs on asthma and lung function: evidence from a genetic association analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_129d0b4cca284296b43e910a6bf1a4cb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_129d0b4cca284296b43e910a6bf1a4cb
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-024-05359-5
